Centrul De Oncologie SF Nectarie S.R.L.

The medical center is at the forefront of research in Non-Small Cell Lung Cancer (NSCLC), focusing on innovative treatment combinations and novel therapeutic agents. The center's research aims to improve outcomes for patients with advanced stages of NSCLC, particularly those with specific genetic mutations or high PD-L1 expression.

• Combination therapies with immunotherapy and chemotherapy
• Targeted therapies for genetic mutations such as EGFR and KRAS
• Comparative studies of novel immunotherapy agents

Through these studies, the center contributes to the development of personalized medicine approaches, enhancing the efficacy and safety of treatments for NSCLC patients.

Research at the center includes pioneering studies in Small Cell Lung Cancer (SCLC), focusing on first-line and relapsed treatment strategies. The center's work is crucial in understanding the disease's aggressive nature and developing effective therapeutic regimens.

• First-line therapy combinations with immunotherapy
• Novel agents for relapsed SCLC
• Comparative efficacy studies of new treatment protocols

These efforts aim to improve survival rates and quality of life for SCLC patients, addressing a significant unmet need in oncology.

The center is actively involved in research on Renal Cell Carcinoma, particularly focusing on advanced and metastatic stages. The research explores the efficacy of combination therapies and novel agents to enhance treatment outcomes.

• Combination of immunotherapy and targeted therapy
• Studies on treatment sequencing and optimization
• Exploration of novel therapeutic agents

By advancing knowledge in this field, the center aims to provide more effective treatment options for patients with renal cell carcinoma.

Research at the center includes cutting-edge studies in Breast Cancer, focusing on advanced and metastatic forms. The center's work is pivotal in developing new treatment strategies and improving patient outcomes.

• Novel therapies for hormone receptor-positive breast cancer
• Immunotherapy combinations for triple-negative breast cancer
• Comparative studies of new and existing treatment protocols

These research efforts aim to enhance the effectiveness of breast cancer treatments, offering hope for improved survival and quality of life.

The center is engaged in significant research on Gastrointestinal Cancers, including esophageal, gastric, and biliary tract cancers. The focus is on developing innovative treatment combinations and improving therapeutic outcomes.

• Combination therapies with immunotherapy and chemotherapy
• Targeted therapies for specific genetic mutations
• Studies on treatment efficacy and safety

Through these studies, the center aims to advance treatment options and improve prognosis for patients with gastrointestinal cancers.